Sequential DC-CIK and radix astragali polysaccharide in post-chemotherapy breast cancer patients
10.3760/cma.j.issn.1673-422X.2011.07.015
- VernacularTitle:乳腺癌化疗后序贯DC-CIK和黄芪多糖抗肿瘤研究进展
- Author:
Xiaobing ZHANG
;
Jian LIU
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Drug therapy;
Dendritic cells;
Killer cells;
Astragalus membranaceus
- From:
Journal of International Oncology
2011;38(7):527-529
- CountryChina
- Language:Chinese
-
Abstract:
Immunity reconstruction treatment using dendritic cells-cytokine induced killer cells (DC-CIK)not only is effective in killing cancer cells, but also enables a quick recovery of chemotherapy patients, thus has received more and more attention for its clinical use. Radix astragali polysaccharide, the extract of traditional Chinese medicine radix astragali, not only has an anti-tumor function, but also can enhance the immunity of cancer patients and reduce the side effects of the chemotherapy. Further researches are needed to validate the combined use of these two treatments in alleviating clinical symptoms of post-chemotherapy breast cancer patients.
